BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25342144)

  • 1. NRAS-mutated melanocytic BAP1-associated intradermal tumor (MBAIT): a case report.
    Blokx WA; Rabold K; Bovenschen HJ; Ligtenberg MJ; Mensenkamp AR; van Lijnschoten G; van Zelst-Stams WA; Groenen PJ
    Virchows Arch; 2015 Jan; 466(1):117-21. PubMed ID: 25342144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAF1 Gene Fusions as a Possible Driver Mechanism in Rare BAP1-Inactivated Melanocytic Tumors: A Report of 2 Cases.
    Donati M; Martinek P; Kastnerova L; Persichetti P; Michal M; Kazakov DV
    Am J Dermatopathol; 2020 Dec; 42(12):961-966. PubMed ID: 32769548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of BAP1 germline mutations in cutaneous melanocytic tumors with loss of BAP1-expression: A pilot study.
    Cabaret O; Perron E; Bressac-de Paillerets B; Soufir N; de la Fouchardière A
    Genes Chromosomes Cancer; 2017 Sep; 56(9):691-694. PubMed ID: 28560743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression.
    Wiesner T; Murali R; Fried I; Cerroni L; Busam K; Kutzner H; Bastian BC
    Am J Surg Pathol; 2012 Jun; 36(6):818-30. PubMed ID: 22367297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors.
    Garfield EM; Walton KE; Quan VL; VandenBoom T; Zhang B; Kong BY; Isales MC; Panah E; Kim G; Gerami P
    J Am Acad Dermatol; 2018 Sep; 79(3):525-534. PubMed ID: 29753057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAP1-deficient and VE1-negative atypical Spitz tumor.
    Requena C; Sanz V; Nagore E; García-Casado Z; Rubio L; Guillén C; Kutzner H
    J Cutan Pathol; 2015 Aug; 42(8):564-7. PubMed ID: 25953246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of molecularly confirmed BAP1 inactivated melanocytic tumor with retention of immunohistochemical expression: A confounding factor.
    Linos K; Atkinson AE; Yan S; Tsongalis GJ; Lefferts JA
    J Cutan Pathol; 2020 May; 47(5):485-489. PubMed ID: 31891422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel insights into the BAP1-inactivated melanocytic tumor.
    Donati M; Martinek P; Steiner P; Grossmann P; Vanecek T; Kastnerova L; Kolm I; Baneckova M; Donati P; Kletskaya I; Kalmykova A; Feit J; Blasch P; Szilagyi D; Baldi A; Persichetti P; Crescenzi A; Michal M; Kazakov DV
    Mod Pathol; 2022 May; 35(5):664-675. PubMed ID: 34857909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined BRAF(V600E)-positive melanocytic lesions with large epithelioid cells lacking BAP1 expression and conventional nevomelanocytes.
    Busam KJ; Sung J; Wiesner T; von Deimling A; Jungbluth A
    Am J Surg Pathol; 2013 Feb; 37(2):193-9. PubMed ID: 23026932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanocytic BAP-1-Mutated Atypical Intradermal Tumor in Two Siblings: A Case Report.
    Kolbach-Rengifo M; Alfaro-Sepúlveda D; Villarroel A; Martin-Parada C; González-Bombardiere S
    Am J Dermatopathol; 2020 Sep; 42(9):694-696. PubMed ID: 32000218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi.
    Francis JH; Grossniklaus HE; Habib LA; Marr B; Abramson DH; Busam KJ
    Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):117-121. PubMed ID: 29332123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
    Piris A; Mihm MC; Hoang MP
    Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline mutations in BAP1 predispose to melanocytic tumors.
    Wiesner T; Obenauf AC; Murali R; Fried I; Griewank KG; Ulz P; Windpassinger C; Wackernagel W; Loy S; Wolf I; Viale A; Lash AE; Pirun M; Socci ND; Rütten A; Palmedo G; Abramson D; Offit K; Ott A; Becker JC; Cerroni L; Kutzner H; Bastian BC; Speicher MR
    Nat Genet; 2011 Aug; 43(10):1018-21. PubMed ID: 21874003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
    Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
    Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAP1-inactivated melanocytic tumor with preserved BAP1 expression? Morphology to the rescue!
    Duncan LM; Tetzlaff MT
    J Cutan Pathol; 2020 May; 47(5):459-461. PubMed ID: 32096236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline BRCA1-associated protein 1 mutation presenting as BAP1 inactivated melanocytic nevi in a child of a father with fatal paraganglioma.
    Watchorn RE; Calonje E; Taibjee SM
    Pediatr Dermatol; 2018 Sep; 35(5):e316-e318. PubMed ID: 29974497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Genomic Profiling of Melanocytic Nevi.
    Colebatch AJ; Ferguson P; Newell F; Kazakoff SH; Witkowski T; Dobrovic A; Johansson PA; Saw RPM; Stretch JR; McArthur GA; Long GV; Thompson JF; Pearson JV; Mann GJ; Hayward NK; Waddell N; Scolyer RA; Wilmott JS
    J Invest Dermatol; 2019 Aug; 139(8):1762-1768. PubMed ID: 30772300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature.
    Haugh AM; Njauw CN; Bubley JA; Verzì AE; Zhang B; Kudalkar E; VandenBoom T; Walton K; Swick BL; Kumar R; Rana HQ; Cochrane S; McCormick SR; Shea CR; Tsao H; Gerami P
    JAMA Dermatol; 2017 Oct; 153(10):999-1006. PubMed ID: 28793149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, dermoscopic, histological and molecular analysis of BAP1-inactivated melanocytic naevus/tumour in two familial cases of BAP1 syndrome.
    Moawad S; Reigneau M; de la Fouchardière A; Soufir N; Schmutz JL; Granel-Brocard F; Phan A; Bursztejn AC
    Br J Dermatol; 2018 Oct; 179(4):973-975. PubMed ID: 29754391
    [No Abstract]   [Full Text] [Related]  

  • 20. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.
    Carbone M; Ferris LK; Baumann F; Napolitano A; Lum CA; Flores EG; Gaudino G; Powers A; Bryant-Greenwood P; Krausz T; Hyjek E; Tate R; Friedberg J; Weigel T; Pass HI; Yang H
    J Transl Med; 2012 Aug; 10():179. PubMed ID: 22935333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.